dc.creator | Mellado M. | |
dc.creator | Mella J. | |
dc.creator | González C. | |
dc.creator | Viña D. | |
dc.creator | Uriarte E. | |
dc.creator | Matos M.J. | |
dc.date.accessioned | 2020-09-02T22:22:53Z | |
dc.date.accessioned | 2022-11-08T20:24:38Z | |
dc.date.available | 2020-09-02T22:22:53Z | |
dc.date.available | 2022-11-08T20:24:38Z | |
dc.date.created | 2020-09-02T22:22:53Z | |
dc.date.issued | 2020 | |
dc.identifier | 101, , - | |
dc.identifier | 00452068 | |
dc.identifier | https://hdl.handle.net/20.500.12728/5286 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145339 | |
dc.language | en | |
dc.publisher | Academic Press Inc. | |
dc.subject | 3-Arylcoumarins | |
dc.subject | 3D-QSAR models | |
dc.subject | Drug design | |
dc.subject | Molecular docking | |
dc.subject | Monoamine oxidase B inhibitors | |
dc.subject | 3 ( 2',4' dimethoxyphenyl) 6 methylcoumarin | |
dc.subject | 3 ( 3',4' dihydroxyphenyl) 6 methylcoumarin | |
dc.subject | 3 ( 3',4' dimethoxyphenyl) 6 methylcoumarin | |
dc.subject | 3 ( 3',5' dimethoxyphenyl) 8 methylcoumarin | |
dc.subject | 3 ( 5' bromo 2',4' dimethoxyphenyl) 6 methylcoumarin | |
dc.subject | 3 arylcoumarin derivative | |
dc.subject | 8 ethoxy 3 ( 3',4' dimethoxyphenyl)coumarin | |
dc.subject | 8 ethoxy 3 ( 3',4',5' trimethoxyphenyl)coumarin | |
dc.subject | 8 methoxy 3 ( 3 tolyl)coumarin | |
dc.subject | amine oxidase (flavin containing) isoenzyme B | |
dc.subject | coumarin derivative | |
dc.subject | dopamine | |
dc.subject | monoamine oxidase B inhibitor | |
dc.subject | monoamine oxidase inhibitor | |
dc.subject | unclassified drug | |
dc.subject | animal cell | |
dc.subject | Article | |
dc.subject | biological activity | |
dc.subject | comparative molecular field analysis | |
dc.subject | comparative molecular similarity indices analysis | |
dc.subject | drug design | |
dc.subject | drug potency | |
dc.subject | drug selectivity | |
dc.subject | drug synthesis | |
dc.subject | enzyme inhibition | |
dc.subject | IC50 | |
dc.subject | molecular docking | |
dc.subject | nonhuman | |
dc.subject | Parkinson disease | |
dc.subject | priority journal | |
dc.subject | probability | |
dc.subject | protein database | |
dc.subject | protein degradation | |
dc.subject | protein function | |
dc.subject | three dimensional quantitative structure activity relationship | |
dc.title | 3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter? | |
dc.type | Article | |